AUG 14, 2019 01:52 PM PDT

Promising Drug Encourages Survival in Pancreatic Cancer

WRITTEN BY: Nouran Amin

Building on almost 20 years of research, a phase 1 clinical trial drug for pancreatic cancer, named ‘AZD1775’, shows promising initial results in a new report by the University of Michigan Rogel Cancer Center. The study was focused on developing therapeutic treatments for pancreatic cancer patients that are on stages far too advanced for surgical interventions. The drug, AZD1775, was designed to work on inhibiting the effects of an enzyme known as ‘Wee1’ for it role in DNA damage repair in cancer cells.

Learn more on Pancreatic Cancer:

"If we can disable the DNA damage response in pancreatic cancer cells, it might eliminate treatment resistance and sensitize the cancer to the effects of both radiation and chemotherapy," says lead study author Kyle Cuneo, M.D., associate professor of radiation oncology at Michigan Medicine.

Current standard treatments drugs involve gemcitabine along with radiotherapy that damage the DNA of cancer cells. However, these treatments are overcome by the cancer as it has its one way of repairing the damage caused by treatments. The limit of effectiveness of these standard treatments has prompted researchers to develop AZD1775—which is unique in leaving normal cells unaffected while shielding the protection away from pancreatic cancer against the effects of radiotherapy and gemcitabine.

"If we're ever going to cure pancreatic cancer, we're going to need effective systemic treatment as well as local therapy. Our data suggests that AZD1775 can do both," says senior study author Ted Lawrence, M.D., Ph.D., Isadore Lampe Professor and chair of radiation oncology at Michigan Medicine.

"Adding AZD1775 to radiation and gemcitabine was relatively well tolerated with encouraging survival results. Further studies with this promising combination are needed," Cuneo says.

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
AUG 22, 2019
Microbiology
AUG 22, 2019
Manuka Honey Kills Cystic Fibrosis Pathogens in Culture
Manuka honey is recognized as a natural antimicrobial agent, and has been used in folk medicines for thousands of years....
AUG 22, 2019
Drug Discovery
AUG 22, 2019
Anti-Diabetic Drug Reduces Anxiety-Like Symptoms
In a study published in the Journal of Neuroscience, an antidiabetic drug called metformin was found to alleviate anxiety-like behavioral symptoms in male ...
AUG 22, 2019
Cancer
AUG 22, 2019
Using VR to Design Medicine
Being able to visualize and precisely understand molecular shapes is a key factor in drug design. Over the years, to envision and better understand molecul...
AUG 22, 2019
Drug Discovery
AUG 22, 2019
Novel Drug Target for Dilating Microvessels
Medical scientists at Augusta University have discovered a natural occurring chemical that dilates blood vessels dilate as well as signaling larger blood v...
AUG 22, 2019
Drug Discovery
AUG 22, 2019
Aspirin: The Good and Bad for Breast Cancer Survivors
Early research has indicated that aspirin usage may increase the survival rate among women with breast cancer. These studies were based on aspirin’s ...
AUG 22, 2019
Health & Medicine
AUG 22, 2019
FDA Approves New Treatment for Extensively Drug-Resistant TB
Last week, the U.S. Food and Drug Administration (FDA) approved a new treatment for a severe form of multi-drug-resistant tuberculosis of the lungs. Accord...
Loading Comments...